≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Suppurative otitis media, unspecified

DOID EFO Endpoint Browser PheWeb

H8_SUP_OTINAS

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — H66.4
  • Hospital discharge: ICD-9 — 3824|3829
  • Cause of death: ICD-10 — H66.4
  • Cause of death: ICD-9 — 3824|3829

2 out of 7 registries used, show all original rules.

1028

4. Check minimum number of events

None

1028

5. Include endpoints

None

1028

6. Filter based on genotype QC (FinnGen only)

1028

Control definitions (FinnGen only)

Control exclude
H8_MIDDLEMASTOID

Extra metadata

Level in the ICD hierarchy
4
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
H66
Name in latin
Otitis media purulenta chronica non specificata

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 14084 6111 7921
Only index persons 11984 5233 6751
Unadjusted period prevalence (%)
Whole population 0.20 0.18 0.22
Only index persons 0.23 0.19 0.26
Median age at first event (years)
Whole population 5.39 6.82 3.92
Only index persons 6.48 9.38 4.23

-FinnGen-

Key figures

All Female Male
Number of individuals 1028 568 460
Unadjusted period prevalence (%) 0.20 0.19 0.20
Median age at first event (years) 31.81 22.25 43.62

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
912
Matched controls
9118
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
H66.4
ICD-10 Finland
Suppurative otitis media, unspecified
1463.0
323.0
575
11
3829X
ICD-9 Finland
Suppurative and unspecified otitis media, Unspecified otitis media
+∞
234.7
215
*
UDC00
NOMESCO Finland
Ear microscopy
17.2
168.5
283
232
H72.0
ICD-10 Finland
Central perforation of tympanic membrane
1953.4
168.1
158
*
H65.3
ICD-10 Finland
Chronic mucoid otitis media
284.8
165.3
164
7
H71
ICD-10 Finland
Cholesteatoma of middle ear
1701.2
151.4
143
*
DCA20
NOMESCO Finland
Insertion of ventilating tube through tympanic membrane
229.6
135.8
137
7
3824A
ICD-9 Finland
Suppurative and unspecified otitis media, Unspecified suppurative otitis media
+∞
134.8
126
*
4122
FHL
Tympanostomy (tympanic tube)
110.9
131.4
141
15
H66.0
ICD-10 Finland
Acute suppurative otitis media
11.1
104.6
212
241
4451
FHL
Guitar cutting
11.8
87.4
170
174
H66.9
ICD-10 Finland
Otitis media, unspecified
10.3
86.0
180
212
H65.2
ICD-10 Finland
Chronic serous otitis media
189.4
83.7
86
5
3812A
ICD-9 Finland
Nonsuppurative otitis media and Eustachian tube disorders, Chronic mucoid otitis media
+∞
80.4
76
*
H90.6
ICD-10 Finland
Mixed conductive and sensorineural hearing loss, bilateral
42.0
78.5
98
26
H66.3
ICD-10 Finland
Other chronic suppurative otitis media
192.0
69.1
71
*
3820A
ICD-9 Finland
Suppurative and unspecified otitis media, Acute suppurative otitis media
+∞
66.5
63
*
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
3.5
66.3
445
1943
DCD00
NOMESCO Finland
Myringoplasty
+∞
60.0
57
*
DC1AD
NOMESCO Finland
Temporalbone CT
132.7
58.6
62
5
DCA10
NOMESCO Finland
Paracentesis of tympanic membrane
34.4
58.4
76
24
38110
ICD-8 Finland
Otitis media without mention of mastoiditis, Chronic
+∞
57.9
55
*
Z01.1
ICD-10 Finland
Examination of ears and hearing
5.0
57.5
210
519
H70.1
ICD-10 Finland
Chronic mastoiditis
+∞
50.5
48
*
S02CA02
ATC
flumetasone and antiinfectives; otic
7.9
50.2
121
174
3821A
ICD-9 Finland
Suppurative and unspecified otitis media, Chronic tubotympanic suppurative otitis media
+∞
48.3
46
*
H74.1
ICD-10 Finland
Adhesive middle ear disease
+∞
47.3
45
*
Z46.1
ICD-10 Finland
Fitting and adjustment of hearing aid
6.8
43.5
116
192
H72.9
ICD-10 Finland
Perforation of tympanic membrane, unspecified
82.5
42.3
47
6
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
3.9
40.7
189
573
DFF00
NOMESCO Finland
Pure tone audiometry
5.5
40.1
127
261
H65.4
ICD-10 Finland
Other chronic nonsuppurative otitis media
+∞
39.9
38
*
H60.9
ICD-10 Finland
Otitis externa, unspecified
5.2
38.3
128
279
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
2.5
37.3
528
3261
H65.1
ICD-10 Finland
Other acute nonsuppurative otitis media
81.4
35.1
39
5
H66.1
ICD-10 Finland
Chronic tubotympanic suppurative otitis media
+∞
34.6
33
*
4939X
ICD-9 Finland
Asthma, unspecified[ASTHMA BRONCHIALE NUD]
12.5
34.1
62
53
H65.9
ICD-10 Finland
Nonsuppurative otitis media, unspecified
124.7
33.9
36
*
H60.8
ICD-10 Finland
Other otitis externa
9.7
33.9
70
77
DEB25
NOMESCO Finland
Attico-antro-mastoidectomy and tympanoplasty
+∞
33.5
32
*
DEB20
NOMESCO Finland
Attico-antro-mastoidectomy and tympanotomy
+∞
33.5
32
*
38700
ICD-8 Finland
Other disease of ear and mastoid process, Cholesteatoma of ear
+∞
32.5
31
*
38210
ICD-8 Finland
Chronic otitis media with mastoiditis
+∞
32.5
31
*
H72.2
ICD-10 Finland
Other marginal perforations of tympanic membrane
+∞
31.4
30
*
Z97.4
ICD-10 Finland
Presence of external hearing-aid
6.8
29.9
78
124
S03CA01
ATC
dexamethasone and antiinfectives; ophthalmic, otic (ophth. and otological prep., corticosteroids and antiinfectives in comb.)
10.1
29.3
59
62
H65.0
ICD-10 Finland
Acute serous otitis media
17.4
28.7
45
27
H60.3
ICD-10 Finland
Other infective otitis externa
10.3
26.8
53
54
DBD20
NOMESCO Finland
Plastic repair of external auditory canal
35.2
26.6
34
10
H90.1
ICD-10 Finland
Conductive hearing loss, unilateral with unrestricted hearing on the contralateral side
13.8
26.2
45
34
4141
FHL
Myringoplasty (also for reasons other than inflammation)
267.6
25.8
26
*
DEB10
NOMESCO Finland
Attico-antro-mastoidectomy
256.6
24.8
25
*
S03CA04
ATC
hydrocortisone and antiinfectives; ophthalmic, otic (ophth. and otological prep., corticosteroids and antiinfectives in comb.)
8.9
24.6
53
63
4121
FHL
Tympanic puncture or parasentosis in general anesthesia or operating room
12.1
24.2
44
38
4741B
ICD-9 Finland
Chronic disease of tonsils and adenoids, Hypertrophy of tonsils and adenoids[HYPERTROPHIA TONSILLAE PHARYNGICAE]
9.1
24.1
51
59
Z3229
NOMESCO Finland
Other healthcare associate professional
3.6
24.0
117
360
H04
ICPC
Ear discharge
6.9
24.0
61
94
J01DA01
ATC
[U] cefalexin; systemic
2.0
23.5
556
3950
DFF15
NOMESCO Finland
Speech audiometry
6.6
22.5
59
95
DEB30
NOMESCO Finland
Radical mastoidectomy
+∞
22.0
21
*
3810A
ICD-9 Finland
Nonsuppurative otitis media and Eustachian tube disorders, Acute nonsuppurative otitis media
+∞
22.0
21
*
J01CA04
ATC
amoxicillin; systemic
2.4
21.2
782
6533
3853A
ICD-9 Finland
Other disorders of middle ear and mastoid, Cholesteatoma of middle ear and mastoid
+∞
20.9
20
*
J01DA08
ATC
[U] cefaclor; oral
2.3
19.8
210
1042
R01AD09
ATC
mometasone; nasal
1.9
19.8
404
2640
1450
FHL
Otomicroscopy
15.0
19.5
32
22
R4135
NOMESCO Finland
Rehabilitation for hearing problems
11.0
19.0
36
34
4742A
ICD-9 Finland
Chronic disease of tonsils and adenoids, Adenoid vegetations
5.2
18.7
59
120
DCD10
NOMESCO Finland
Tympanoplasty
193.6
18.6
19
*
H90.0
ICD-10 Finland
Conductive hearing loss, bilateral
16.6
18.4
29
18
J01DA09
ATC
[U] cefadroxil; inhalant, oral
2.1
18.1
263
1495
TDA90
NOMESCO Finland
Removal wax from ear
11.4
17.8
33
30
DGW00
NOMESCO Finland
Dilatation of eustachian tube
+∞
17.8
17
*
R01AD08
ATC
fluticasone; nasal
2.0
17.1
259
1490
H95.8
ICD-10 Finland
Other postprocedural disorders of ear and mastoid process
+∞
16.7
16
*
3842A
ICD-9 Finland
Other disorders of tympanic membrane, Perforation of tympanic membrane
+∞
16.7
16
*
TDW99
NOMESCO Finland
Other minor procedure in surgery of ear, nose and larynx
5.6
16.4
48
90
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
3.3
16.3
84
269
DAX08
NOMESCO Finland
Fitting of hearing aid
4.9
15.8
52
111
J01MA02
ATC
ciprofloxacin; systemic
1.9
15.7
307
1934
4147
FHL
Radical surgery, cavity filling and middle ear and / or eardrum plastic
+∞
15.7
15
*
4150
FHL
Tympanoplasty (including for reasons other than inflammation)
+∞
15.7
15
*
H60.4
ICD-10 Finland
Cholesteatoma of external ear
86.5
15.6
17
*
H73.1
ICD-10 Finland
Chronic myringitis
162.5
15.5
16
*
J01DB01
ATC
cefalexin; oral
1.9
15.2
721
6040
DAX00
NOMESCO Finland
Adjustment or review of hearing aid
4.7
14.9
51
114
H66.2
ICD-10 Finland
Chronic atticoantral suppurative otitis media
+∞
14.6
14
*
38100
ICD-8 Finland
Otitis media without mention of mastoiditis, Acute
+∞
14.6
14
*
H95.1
ICD-10 Finland
Other disorders following mastoidectomy
152.2
14.5
15
*
H90.7
ICD-10 Finland
Mixed conductive and sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side
13.6
14.3
24
18
R5120
NOMESCO Finland
Preparation of an aid
6.4
14.2
37
60
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
2.1
14.0
178
946
R5130
NOMESCO Finland
Repair work or maintenance done on the aid
6.0
13.9
38
66
H66
ICD-10 Finland
Suppurative and unspecified otitis media
4.9
13.6
44
93
4144
FHL
Mastoidectomy or aticomastoidectomy
+∞
13.6
13
*
DEA10
NOMESCO Finland
Attico-antrotomy
+∞
13.6
13
*
TDM10
NOMESCO Finland
Puncture of maxillary antrum
4.3
13.4
49
118
4859X
ICD-9 Finland
Bronchopneumonia, organism unspecified[PNEUMONIA NUD]
5.0
12.9
41
85
R03AC02
ATC
salbutamol; inhalant
1.7
12.9
449
3329
H68.1
ICD-10 Finland
Obstruction of Eustachian tube
12.5
12.6
22
18
UDH02
NOMESCO Finland
Rhinopharyngoscopy
3.2
12.6
68
227
4145
FHL
Tympanomastoidectomy, includes possible tympanoplasty
+∞
12.5
12
*
38402
ICD-8 Finland
Other inflammatory diseases of ear, Rhinosalpingitis (otosalpingitis) non definita
+∞
12.5
12
*
38199
ICD-8 Finland
Otitis media without mention of mastoiditis, Unspecified
+∞
12.5
12
*
DEB00
NOMESCO Finland
Cortical mastoidectomy
131.6
12.5
13
*
ZXA10
NOMESCO Finland
Bilateral
2.0
11.8
160
866
J01FF01
ATC
clindamycin; systemic
1.8
11.7
215
1305
H60.5
ICD-10 Finland
Acute otitis externa, noninfective
12.7
11.7
20
16
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
2.4
11.6
98
429
4660A
ICD-9 Finland
Acute bronchitis and bronchiolitis, Acute bronchitis
8.8
11.6
24
28
H91.9
ICD-10 Finland
Hearing loss, unspecified
3.9
11.5
46
121
J01FA10
ATC
azithromycin; systemic
1.6
11.5
512
4014
J01DA06
ATC
[U] cefuroxime; systemic
2.1
11.2
131
668
J45.9
ICD-10 Finland
Asthma, unspecified
2.0
11.2
150
808
H72.8
ICD-10 Finland
Other perforations of tympanic membrane
25.3
11.2
15
6
H61.2
ICD-10 Finland
Impacted cerumen
3.2
11.1
59
195
R01AD05
ATC
budesonide; nasal
2.6
10.7
77
307
H02AB06
ATC
prednisolone; systemic
1.6
10.7
353
2541
4930B
ICD-9 Finland
Asthma, Extrinsic asthma[EXTRINSIC ASTHMA CUM EXACERBATIONE]
10.2
10.5
20
20
J45.1
ICD-10 Finland
Nonallergic asthma
2.7
10.5
71
275
H95.0
ICD-10 Finland
Recurrent cholesteatoma of postmastoidectomy cavity
111.1
10.4
11
*
DCA30
NOMESCO Finland
Exploration of middle ear
+∞
10.4
10
*
4808X
ICD-9 Finland
Viral pneumonia, Pneumonia due to other virus not elsewhere classified
+∞
10.4
10
*
H29
ICPC
Ear symptom/complaint other
2.3
10.4
94
426
EMB30
NOMESCO Finland
Adenotomy
4.1
10.2
39
99
R03BA05
ATC
fluticasone; inhalant
1.9
10.1
165
954
J33.0
ICD-10 Finland
Polyp of nasal cavity
4.7
10.1
33
72
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
2.6
9.6
71
290
R03AK06
ATC
salmeterol and fluticasone; inhalant
2.1
9.5
113
579
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
4.2
9.5
35
86
H90.4
ICD-10 Finland
Sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side
4.0
9.5
37
96
4151
FHL
Reoperation for chronic otitis media
101.0
9.4
10
*
DCW00
NOMESCO Finland
Removal of ventilating tube from tympanic membrane
+∞
9.4
9
*
H72.1
ICD-10 Finland
Attic perforation of tympanic membrane
+∞
9.4
9
*
DCW99
NOMESCO Finland
Other operation on eardrum and middle ear
+∞
9.4
9
*
R03DA04
ATC
theophylline; systemic, rectal
3.0
9.3
51
174
H02AB07
ATC
prednisone; oral
2.1
9.2
108
549
H01
ICPC
Ear pain/earache
2.0
9.2
116
609
R03BA02
ATC
budesonide; inhalant
1.9
9.2
151
878
H69.0
ICD-10 Finland
Patulous Eustachian tube
37.0
9.0
11
*
4659X
ICD-9 Finland
Acute upper respiratory infections of multiple or unspecified sites, Unspecified site
5.0
8.9
27
55
J45.0
ICD-10 Finland
Predominantly allergic asthma
2.1
8.6
94
465
H92.1
ICD-10 Finland
Otorrhoea
27.8
8.5
11
*
TDC10
NOMESCO Finland
Removal of ventilating tube from tympanic membrane
90.8
8.4
9
*
H70.0
ICD-10 Finland
Acute mastoiditis
+∞
8.3
8
*
J01EB05
ATC
sulfafurazole; systemic
8.6
8.3
17
20
H60.1
ICD-10 Finland
Cellulitis of external ear
5.9
8.3
22
38
H60
ICD-10 Finland
Otitis externa
2.9
8.3
48
169
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.8
8.2
136
791
N02BE01
ATC
paracetamol; systemic, rectal
1.6
8.2
698
6133
S02AA30
ATC
antiinfectives, combinations; otic
2.2
8.2
84
406
DFF30
NOMESCO Finland
Loudness discomfort Level (LDL)
5.2
7.9
23
45
R51.80
ICD-10 Finland
Headache
1.8
7.9
135
790
4930A
ICD-9 Finland
Asthma, Extrinsic asthma[EXTRINSIC ASTHMA SINE EXACERBATIONE]
6.2
7.9
20
33
4931A
ICD-9 Finland
Asthma, Intrinsic asthma[INTRINSIC ASTHMA SINE EXACERBATIONE]
10.9
7.8
14
13
4630A
ICD-9 Finland
Acute tonsillitis[TONSILLITIS ACUTA]
7.0
7.8
18
26
J01FA01
ATC
erythromycin; systemic
1.7
7.6
156
969
DEE00
NOMESCO Finland
Osseous fixation of hearing aid
80.7
7.4
8
*
ZXA05
NOMESCO Finland
Left side
1.7
7.4
176
1140
R03BC01
ATC
cromoglicic acid; inhalant
3.9
7.3
28
73
38401
ICD-8 Finland
Other inflammatory diseases of ear, Rhinosalpingitis (otosalpingitis) chronica adhaesiva
+∞
7.3
7
*
H74.2
ICD-10 Finland
Discontinuity and dislocation of ear ossicles
+∞
7.3
7
*
H73.8
ICD-10 Finland
Other specified disorders of tympanic membrane
+∞
7.3
7
*
3811A
ICD-9 Finland
Nonsuppurative otitis media and Eustachian tube disorders, Chronic serous otitis media
+∞
7.3
7
*
S02AA03
ATC
boric acid; otic
9.4
7.3
14
15
4222
FHL
Endonasal etmoidectomy
9.4
7.3
14
15
4640A
ICD-9 Finland
Acute laryngitis and tracheitis, Acute laryngitis
4.7
7.2
23
50
R01BA52
ATC
pseudoephedrine, combinations; oral
1.6
7.2
182
1197
ZXA00
NOMESCO Finland
Right side
1.6
7.1
188
1253
N02AX02
ATC
tramadol; systemic, rectal
1.5
7.1
284
2093
H92.0
ICD-10 Finland
Otalgia
2.5
6.9
53
223
4610A
ICD-9 Finland
Acute sinusitis, Maxillary
4.7
6.9
22
48
N02AJ06
ATC
codeine and paracetamol; systemic
1.5
6.9
281
2078
J01AA02
ATC
doxycycline; systemic
1.4
6.8
550
4663
WX408
NOMESCO Finland
General anesthesy, balanced
1.6
6.8
206
1421
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
1.5
6.8
240
1717
H72
ICD-10 Finland
Perforation of tympanic membrane
40.3
6.8
8
*
A02BC01
ATC
omeprazole; systemic
1.6
6.7
197
1348
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.2
6.7
67
322
H60.0
ICD-10 Finland
Abscess of external ear
7.9
6.6
14
18
H70
ICPC
Otitis externa
3.8
6.6
26
70
4661A
ICD-9 Finland
Acute bronchitis and bronchiolitis, Acute bronchiolitis
12.3
6.6
11
9
4730A
ICD-9 Finland
Chronic sinusitis, Maxillary
4.8
6.6
20
42
J35.2
ICD-10 Finland
Hypertrophy of adenoids
3.2
6.5
32
103
Z01.8
ICD-10 Finland
Other specified special examinations
1.6
6.5
160
1044
R03AC03
ATC
terbutaline; inhalant
1.8
6.5
110
645
DNB20
NOMESCO Finland
Endoscopic ethmoidectomy
3.6
6.4
27
77
DDD05
NOMESCO Finland
Plastic repair of ossicular chain
+∞
6.3
6
*
4931B
ICD-9 Finland
Asthma, Intrinsic asthma[INTRINSIC ASTHMA CUM EXACERBATIONE]
26.8
6.2
8
*
7803A
ICD-9 Finland
General symptoms, Convulsions
4.1
6.2
22
54
C09AA05
ATC
ramipril; oral
1.7
6.2
141
900
R03DC03
ATC
montelukast; oral
1.7
6.2
119
724
J47
ICD-10 Finland
Bronchiectasis
4.5
6.2
20
45
J01DC04
ATC
cefaclor; oral
6.3
6.2
15
24
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.6
6.2
173
1170
Z46.8
ICD-10 Finland
Fitting and adjustment of other specified devices
3.9
6.1
23
60
Z50.1
ICD-10 Finland
Other physical therapy
2.6
6.1
41
162

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3007853) Bacteria identified in Skin by Aerobe culture
236
892
3.14
46.97
2.7
1.6
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
201
1036
2.17
19.54
2.2
1.9
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
61
170
3.75
19.17
4.4
4.9
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
169
850
2.18
17.34
1.7
1.4
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
361
2533
1.65
12.53
3.4
3.1
u/l
30.4
30.5
0.02
343
2402
(3033705) Calcium.ionized [Moles/volume] in Venous blood
33
87
3.88
11.26
3.8
2.8
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
318
2265
1.58
9.91
3.0
2.5
u/l
51.5
56.0
2.30
297
2107
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
663
5604
1.51
8.96
7.6
6.9
u/l
77.0
77.5
0.13
632
5241
(3026782) Osmolality of Urine
221
1474
1.64
8.92
3.4
2.6
mosm/kgh2o
584.3
557.9
0.80
187
1256
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
465
3717
1.46
7.94
4.9
5.7
umol/l
10.2
11.9
3.45
449
3489
(3019150) Specific gravity of Urine by Refractometry
255
1804
1.55
7.93
4.0
3.7
kg/l
1.0
1.0
0.12
49
276
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
211
1435
1.59
7.77
1.6
1.7
pmol/l
156354011.0
14716145.8
1.14
181
1196
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
67
325
2.13
7.46
3.3
3.0
%
0.7
0.7
0.59
61
312
(3000330) Specific gravity of Urine by Test strip
73
370
2.05
7.25
4.9
3.6
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
401
3169
1.43
7.03
4.4
3.5
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
107
624
1.80
6.99
4.3
4.4
%
1.0
0.9
0.03
27
176
(3020682) Albumin/Creatinine [Ratio] in Urine
260
1894
1.50
6.94
4.2
4.1
mg/mmol
12.8
10.3
0.31
172
1242
(3021440) Promyelocytes/100 leukocytes in Blood
102
592
1.80
6.78
4.1
4.4
%
0.1
0.2
0.18
25
164
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
231
1670
1.49
6.33
1.6
1.8
mg/l
0.9
1.2
1.16
166
1221
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
468
3869
1.38
6.06
4.3
4.1
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
329
2563
1.42
6.05
4.3
3.4
ng/l
43.8
56.8
0.30
224
1619
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
41
179
2.34
5.92
1.6
1.9
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
128
822
1.64
5.90
5.5
6.1
mmol/l
104.5
104.3
0.19
122
801
(3026008) Bacteria identified in Urine by Culture
304
2351
1.42
5.78
3.1
2.8
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
112
702
1.67
5.68
5.7
3.9
mmol/l
1.8
1.9
0.26
90
550
(3002385) Erythrocyte distribution width [Ratio]
785
7112
1.44
5.66
18.6
14.5
%
13.6
13.4
1.49
766
6973
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
883
8189
1.55
5.65
16.3
12.0
mg/l
20.8
22.4
0.75
715
6348
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
424
3479
1.37
5.63
7.2
6.1
mmol/l
1.2
1.2
0.19
372
2941
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
239
1783
1.44
5.51
3.4
3.0
ng/l
1723.7
1293.0
0.71
203
1488
(3013650) Neutrophils [#/volume] in Blood by Automated count
537
4585
1.36
5.48
8.6
8.5
e9/l
4.3
4.1
1.55
481
4003
(3019550) Sodium [Moles/volume] in Serum or Plasma
855
7902
1.49
5.28
17.1
13.4
mmol/l
139.6
139.6
0.06
837
7656
(3005322) IgE [Units/volume] in Serum or Plasma
86
513
1.74
5.23
1.5
1.2
u/ml
378.5
193.9
0.40
81
465
(3023103) Potassium [Moles/volume] in Serum or Plasma
856
7917
1.48
5.23
17.1
13.5
mmol/l
4.0
3.9
0.58
835
7645
(3035350) Ketones [Presence] in Urine by Test strip
483
4076
1.35
5.23
4.2
3.4
estimate
0.0
0.0
0.50
84
817
(3021601) Nitrite [Presence] in Urine by Test strip
483
4078
1.35
5.20
6.1
4.7
estimate
0.0
0.0
0.00
87
830
(3002179) Metamyelocytes/100 leukocytes in Blood
93
568
1.70
5.20
3.9
4.2
%
0.6
0.4
0.36
17
131
(3013707) Erythrocyte sedimentation rate by Westergren method
645
5692
1.36
5.17
4.3
3.8
mm/h
11.7
10.5
1.33
610
5247
(3009261) Glucose [Presence] in Urine by Test strip
487
4127
1.34
5.08
4.4
3.4
estimate
0.0
0.0
0.50
79
810
(3030981) Hyaline casts [#/volume] in Urine by Automated count
65
360
1.86
5.06
3.8
2.8
e6/l
0.3
0.2
0.15
65
354
(3025159) Blasts/100 leukocytes in Blood
91
558
1.69
5.02
4.5
4.5
%
0.0
0.0
0.96
20
136
(3032080) INR in Blood by Coagulation assay
338
2714
1.37
5.00
9.5
8.1
inr
1.3
1.2
0.58
129
818
(40760892) CBC W Ordered Manual Differential panel - Blood
244
1858
1.41
4.97
4.9
4.2
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
518
4439
1.34
4.97
5.1
4.6
mmol/l
6.6
6.5
0.70
469
4037
(3002030) Lymphocytes/100 leukocytes in Blood
466
3938
1.33
4.89
7.0
5.9
%
28.1
29.2
1.45
450
3700
(3022948) Iron [Moles/volume] in Serum or Plasma
157
1113
1.48
4.67
2.9
2.2
umol/l
12.7
13.8
0.99
148
1028
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
171
1235
1.46
4.63
1.3
1.3
iu/ml
19.6
30.3
1.45
43
359
(3006504) Eosinophils/100 leukocytes in Blood
446
3767
1.32
4.62
6.9
5.8
%
3.0
2.8
0.56
427
3526
(3018010) Neutrophils/100 leukocytes in Blood
457
3881
1.32
4.52
6.7
5.7
%
57.3
56.2
1.31
443
3663
(3019198) Lymphocytes [#/volume] in Blood
484
4146
1.32
4.49
6.7
5.8
e9/l
2.0
2.0
0.45
440
3670
(3000850) Epithelial cells [#/volume] in Urine
207
1558
1.41
4.47
2.5
2.4
e6/l
6.1
6.4
0.09
182
1374
(3019069) Monocytes/100 leukocytes in Blood
447
3793
1.32
4.42
7.1
6.1
%
8.4
8.3
0.07
428
3578
(3002582) Erythrocytes [#/volume] in Urine
288
2294
1.35
4.40
3.4
3.0
e6/l
40.1
87.8
0.76
221
1736
(3041096) Erythrocytes [Presence] in Urine by Automated
295
2360
1.35
4.38
4.3
3.0
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
373
3092
1.32
4.33
2.5
2.2
nmol/l
73.5
73.9
0.12
349
2799
(3006315) Basophils [#/volume] in Blood
467
4006
1.30
4.19
6.8
5.8
e9/l
0.0
0.0
0.38
416
3483
(3013115) Eosinophils [#/volume] in Blood
480
4133
1.30
4.19
7.1
6.1
e9/l
0.2
0.2
2.23
425
3659
(3022096) Basophils/100 leukocytes in Blood
429
3640
1.31
4.17
6.9
5.9
%
0.7
0.6
0.34
410
3422
(3001604) Monocytes [#/volume] in Blood
465
3991
1.30
4.14
6.8
5.8
e9/l
0.6
0.6
3.07
414
3465
(3013512) EKG study
244
1911
1.36
4.12
4.9
3.6
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
685
6196
1.32
4.09
4.1
3.9
pmol/l
14.7
14.7
0.25
637
5613
(3010726) Horse dander IgE Ab [Units/volume] in Serum
41
210
1.99
4.06
1.0
1.1
u/ml
2.3
2.2
—
8
61
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
56
322
1.78
3.92
6.9
10.7
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
268
2148
1.33
3.87
1.7
1.6
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
237
1870
1.35
3.79
4.7
4.0
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
316
2604
1.31
3.73
6.4
6.0
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
261
2094
1.33
3.72
3.1
2.9
e6/l
0.2
0.4
1.69
193
1554
(3044640) Blood type and Crossmatch panel - Blood
304
2494
1.31
3.70
2.2
2.3
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
357
2996
1.29
3.66
5.2
4.7
g/l
35.9
36.2
0.48
339
2779
(3009508) Creatinine [Moles/volume] in Urine
275
2229
1.32
3.64
3.4
3.2
mmol/l
7.5
8.0
1.09
235
1872
(3024980) IgG subclass 4 [Mass/volume] in Serum
25
112
2.26
3.50
1.5
1.9
g/l
0.7
0.7
0.10
16
91
(3004789) Transferrin [Mass/volume] in Serum or Plasma
138
1009
1.42
3.49
3.0
2.1
g/l
2.4
2.4
0.13
127
929
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
74
475
1.60
3.48
4.9
4.1
mmol/l
1.2
1.5
0.30
56
343
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
76
493
1.58
3.42
4.5
3.0
ng/l
153.8
191.8
0.49
59
449
(3037467) Urinalysis macro (dipstick) panel - Urine
631
5711
1.27
3.41
5.1
4.0
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
214
1689
1.34
3.39
2.7
2.6
umol/l
14199.0
6261.8
0.95
192
1483
(3022621) pH of Urine by Test strip
79
519
1.57
3.37
4.3
2.8
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
155
1164
1.39
3.37
1.3
1.3
u/ml
13.2
9.5
0.27
77
452
(3018095) Leukocytes [#/volume] in Urine
334
2804
1.28
3.36
4.0
3.4
e6/l
69.8
70.4
0.01
237
1873
(40768797) Stomach Pathology biopsy report
124
897
1.43
3.33
1.2
1.2
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
226
1806
1.32
3.28
3.5
3.4
mg/l
686.7
237.8
0.53
143
1205
(40761511) CBC panel - Blood by Automated count
902
8585
1.41
3.26
15.2
11.3
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
15
54
2.80
3.26
2.1
2.9
mg/l
63.1
17.0
—
10
45
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
83
557
1.53
3.24
4.1
3.3
mmol/l
1.2
1.2
0.54
71
473
(3009343) pH of Capillary blood
76
500
1.56
3.23
4.8
4.0
ph
7.4
7.4
—
7
47
(3028192) IgG subclass 2 [Mass/volume] in Serum
16
60
2.69
3.23
1.8
1.4
g/l
2.8
2.9
0.04
11
45
(3027135) IgG subclass 1 [Mass/volume] in Serum
16
60
2.69
3.23
1.8
1.4
g/l
6.5
6.9
0.12
11
46
(3024139) IgG subclass 3 [Mass/volume] in Serum
16
60
2.69
3.23
1.8
1.4
g/l
0.5
0.4
0.24
11
46
(3011412) CD3 cells [#/volume] in Blood
20
85
2.38
3.16
1.7
2.1
e9/l
1.1
1.2
0.19
12
42
(3013727) Leukocytes other/100 leukocytes in Blood
9
20
4.53
3.11
1.8
4.8
%
49.6
48.9
—
9
20
(3021589) Normoblasts [#/volume] in Blood
418
3635
1.25
3.07
10.4
8.6
e9/l
0.0
0.0
0.66
345
2963
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
15
56
2.70
3.06
1.9
2.1
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
11
34
3.26
3.06
1.0
1.6
—
—
—
0
0
(4062490)
16
62
2.60
3.05
1.8
1.4
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
43
248
1.77
3.03
1.0
1.2
u/ml
2.4
2.0
0.10
20
118
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
102
728
1.44
2.96
5.2
7.4
kpa
5.2
5.1
0.39
96
698
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
61
390
1.60
2.95
1.9
2.0
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
102
729
1.44
2.94
5.2
7.4
kpa
12.0
12.9
0.68
96
703
(3003396) Base excess in Arterial blood by calculation
101
721
1.44
2.93
5.4
7.5
mmol/l
1.6
1.2
0.51
71
559
(3044941) Cell count panel - Synovial fluid
20
89
2.27
2.88
1.5
1.5
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
7
13
5.41
2.87
2.1
2.0
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
68
450
1.55
2.85
1.6
1.5
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
204
1639
1.30
2.83
1.3
1.5
nmol/l
18.3
20.3
1.61
184
1399
(3021901) Oxygen saturation in Capillary blood
24
117
2.08
2.78
3.5
2.2
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
37
210
1.79
2.77
1.0
1.1
u/ml
0.4
1.8
1.24
17
105
(36304419) Bacteria [Presence] in Urine
248
2051
1.28
2.75
3.0
2.8
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
890
8500
1.35
2.72
10.4
8.9
u/l
26.9
26.0
0.54
861
8179
(3003888) Timothy IgE Ab [Units/volume] in Serum
38
219
1.76
2.71
1.0
1.1
u/ml
5.6
7.9
0.31
17
135
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
6
10
6.03
2.70
5.5
5.0
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
48
296
1.65
2.70
2.6
2.7
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
314
2682
1.25
2.63
3.5
3.0
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
596
5447
1.22
2.59
3.2
2.9
u/l
41.5
39.7
0.29
572
5116
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
125
948
1.36
2.58
3.1
2.2
%
22.2
23.6
0.46
107
816
(44806420)
8
20
4.02
2.57
2.1
2.5
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
765
7186
1.25
2.53
14.4
10.8
ml/min/173m2
88.4
88.7
0.09
607
5741
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
150
1173
1.33
2.53
3.3
2.8
e6/l
2.6
2.3
0.21
79
628
(1616796) Gas panel - Central venous blood
26
136
1.93
2.52
5.0
2.2
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
27
144
1.90
2.48
1.9
2.1
g/l
131.2
129.8
0.14
20
109
(3003338) MCHC [Mass/volume]
770
7248
1.25
2.44
19.1
15.1
g/l
333.1
333.5
0.66
764
7204
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
7
17
4.14
2.36
1.3
1.9
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
772
7282
1.24
2.33
4.3
3.9
mmol/l
5.9
5.8
2.12
725
6634
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
18
85
2.14
2.29
1.1
1.4
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
263
2236
1.24
2.26
4.4
3.6
estimate
0.0
0.0
0.69
83
811
(3019060) Gas panel - Arterial blood
62
425
1.49
2.26
3.6
5.5
—
—
—
0
0
(4198724)
15
66
2.29
2.25
2.3
2.2
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
74
527
1.44
2.22
1.9
1.6
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
17
80
2.14
2.19
4.4
2.5
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
778
7363
1.23
2.17
5.0
4.5
mu/l
2.0
1.8
1.03
732
6756
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
14
62
2.27
2.08
1.9
2.1
%
17.0
10.6
—
7
36
(40768441) Liver Pathology biopsy report
0
55
0.00
2.07
0.0
1.2
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
153
1234
1.28
2.07
2.8
2.6
e6/l
0.7
0.9
0.56
83
684
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
15
69
2.19
2.05
1.7
1.3
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
220
1854
1.24
2.05
3.6
3.4
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
710
6678
1.20
2.02
6.2
5.0
mmol/mol
39.8
38.7
1.87
671
6207
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
14
63
2.24
2.01
1.1
1.6
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
72
977
0.72
2.01
1.3
1.3
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
101
775
1.34
1.97
1.9
1.8
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
115
900
1.31
1.96
7.3
5.3
mmol/l
1.1
1.1
1.38
108
827
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
140
1125
1.28
1.95
2.0
1.8
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
676
6339
1.19
1.95
3.7
3.6
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
98
750
1.34
1.95
1.8
2.0
nmol/l
377.9
375.2
0.04
93
691
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
100
769
1.33
1.92
1.9
1.7
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
17
85
2.02
1.91
1.1
2.0
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
110
860
1.31
1.89
2.0
2.7
umol/l
4.0
8.3
7.69
88
729
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
236
2023
1.22
1.86
2.4
2.0
u/l
257.6
250.7
0.03
225
1916
(3051387) C reactive protein [Mass/volume] in Capillary blood
28
168
1.68
1.82
2.9
3.3
mg/l
19.2
27.8
1.38
19
108
(3004775) Volume in Urine collected for unspecified duration
12
53
2.28
1.81
1.8
2.5
ml
604.7
541.4
—
7
35
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
36
231
1.58
1.81
1.3
1.2
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
29
176
1.67
1.81
1.7
1.4
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
8
29
2.77
1.79
1.0
1.7
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
33
208
1.61
1.78
2.7
2.9
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
354
3161
1.18
1.78
6.0
5.6
mmol/l
1.2
1.2
0.60
327
2855
(3023430) Cat dander IgE Ab [Units/volume] in Serum
26
154
1.71
1.77
1.0
1.1
u/ml
13.9
7.2
0.34
12
76
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
6
18
3.35
1.75
1.0
1.1
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
6
18
3.35
1.75
1.0
1.1
%
87.5
95.1
—
6
18
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
787
7512
1.20
1.74
4.2
3.7
mmol/l
4.5
4.6
1.65
746
6990
(3028026) IgM [Mass/volume] in Serum or Plasma
67
493
1.38
1.72
1.7
1.7
g/l
1.5
1.4
0.07
62
452
(3035941) MCH [Entitic mass]
952
9281
1.34
1.72
22.5
17.4
pg
30.0
30.1
0.94
943
9162
(3024731) MCV [Entitic volume]
952
9281
1.34
1.72
22.5
17.5
fl
89.9
90.0
0.59
943
9163
(3022313) Gas panel - Capillary blood
53
375
1.44
1.70
4.9
4.3
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
952
9283
1.34
1.70
22.6
17.5
e12/l
4.5
4.5
0.27
938
9029
(3012095) Magnesium [Moles/volume] in Serum or Plasma
131
1064
1.26
1.70
4.2
3.5
mmol/l
0.8
0.8
0.04
122
990
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
24
141
1.72
1.69
1.1
1.4
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
952
9284
1.34
1.69
22.7
17.6
e9/l
7.1
6.8
3.35
937
9028
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
782
7467
1.20
1.68
4.1
3.7
mmol/l
1.4
1.4
1.97
740
6919
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
314
2791
1.18
1.65
2.0
1.9
pmol/l
96.9
95.2
0.27
178
1498
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
7
25
2.81
1.65
1.1
2.1
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
7
25
2.81
1.65
1.3
2.0
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
952
9288
1.33
1.64
22.8
17.6
g/l
135.6
135.7
0.11
944
9161
(3037522) Nuclear Ab [Titer] in Serum
127
1032
1.26
1.64
1.3
1.3
titre
317.9
513.2
1.23
19
201
(3013139) Helicobacter pylori Ag [Presence] in Stool
66
490
1.37
1.62
1.2
1.2
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
5
14
3.58
1.61
1.4
1.3
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
54
388
1.41
1.61
1.8
1.6
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
6
20
3.01
1.58
2.0
1.6
mmol/l
1.2
1.2
—
6
20
(3031040) Bacteria [#/volume] in Urine by Automated count
585
5471
1.16
1.58
5.1
4.2
e6/l
203.2
1808.4
—
9
76
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
20
114
1.77
1.57
4.4
2.2
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
752
7172
1.18
1.57
3.8
3.4
mmol/l
1.3
1.2
1.54
707
6633
(3000475) Leukocytes [#/volume] in Synovial fluid
24
145
1.67
1.55
1.6
1.6
e6/l
6653.4
14319.7
0.80
18
110
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
25
153
1.65
1.54
1.4
1.5
mmol/l
7.4
6.8
0.28
15
101
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
8
33
2.43
1.54
1.8
1.1
—
—
—
0
0
(4010399)
64
478
1.36
1.53
1.7
1.4
—
—
—
0
0
(3000012) Reticulocyte production index
0
42
0.00
1.53
0.0
2.0
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
5
15
3.34
1.52
2.0
1.0
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
5
15
3.34
1.52
2.0
1.0
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
5
15
3.34
1.52
2.0
1.0
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
19
108
1.77
1.51
2.2
1.4
—
12.7
—
0
16
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
229
1998
1.19
1.49
2.3
2.2
mg/l
3.1
2.8
0.80
197
1704
(3019309) Folate [Moles/volume] in Red Blood Cells
148
1239
1.23
1.48
1.7
1.7
nmol/l
1163.5
1170.0
0.03
121
926
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
34
228
1.51
1.45
1.3
1.2
u/ml
337.1
235.4
0.98
23
127
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
7
28
2.51
1.45
1.0
1.7
—
—
—
0
0
(3011648) Oxygen content in Venous blood
11
52
2.13
1.44
2.8
5.8
%
11.2
10.8
0.11
11
52
(3007461) Platelets [#/volume] in Blood
949
9275
1.30
1.44
22.7
17.5
e9/l
254.8
251.5
0.94
937
9039
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
12
59
2.05
1.43
1.6
1.1
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
6
22
2.74
1.43
2.8
3.0
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
6
22
2.74
1.43
2.5
2.6
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
6
22
2.74
1.43
2.8
3.0
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
214
1863
1.19
1.43
1.9
1.4
g/l
2.4
2.3
0.80
138
1147
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
20
118
1.71
1.42
1.3
1.7
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
9
40
2.26
1.40
1.1
1.8
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
9
40
2.26
1.40
1.1
1.8
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
9
40
2.26
1.40
1.1
1.8
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
9
40
2.26
1.40
1.1
1.8
—
—
—
0
0
(3008898) HLA-B27 [Presence]
47
339
1.40
1.40
1.1
1.1
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
85
672
1.29
1.39
1.9
1.9
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
17
96
1.78
1.39
1.1
1.1
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
11
53
2.09
1.38
3.9
3.0
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
86
682
1.28
1.38
1.9
2.0
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
792
7614
1.17
1.37
4.5
4.1
mmol/l
2.7
2.7
0.66
748
7035
(3028300) Cannabinoids [Presence] in Urine
86
684
1.28
1.35
1.9
2.0
—
—
—
0
0
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
0
37
0.00
1.34
0.0
1.2
—
76.2
—
0
32
(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma
9
42
2.15
1.34
1.1
1.2
%
75.3
72.5
—
9
37
(3014133) Dog dander IgE Ab [Units/volume] in Serum
26
168
1.56
1.32
1.0
1.1
u/ml
8.6
6.6
—
8
75
(3000764) Benzodiazepines [Presence] in Urine
85
678
1.28
1.31
2.0
2.0
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
54
405
1.35
1.29
1.3
1.3
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
427
3946
1.14
1.28
3.2
2.7
ug/l
107.1
97.1
0.23
406
3665
(3044889) 12 lead EKG panel
522
4889
1.14
1.27
3.7
3.4
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
90
727
1.26
1.26
3.5
3.0
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
61
468
1.32
1.26
2.8
2.6
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
18
107
1.69
1.26
1.1
1.4
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
96
782
1.25
1.25
2.6
4.3
u/l
246.0
251.0
0.08
90
744
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
6
25
2.41
1.24
1.7
1.3
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
8
36
2.23
1.24
1.4
3.3
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
27
179
1.52
1.24
1.9
1.7
mmol/l
7.7
7.3
—
7
115
(3020191) Ethanol [Moles/volume] in Serum or Plasma
12
63
1.91
1.23
1.8
1.5
promille
1.4
1.3
—
7
49
(4024509)
11
56
1.97
1.22
2.0
1.3
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
10
49
2.05
1.22
1.0
1.6
—
—
—
0
0
(3027923) C peptide [Moles/volume] in Serum or Plasma
8
37
2.17
1.21
2.5
1.5
nmol/l
0.8
1.1
—
8
27
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
16
93
1.73
1.21
1.0
1.4
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
6
26
2.31
1.18
1.0
1.1
—
—
—
0
0
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
8
38
2.11
1.18
1.0
1.2
—
90.4
—
0
5
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
18
110
1.65
1.15
2.4
1.3
—
—
—
0
0
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
0
35
0.00
1.15
0.0
1.2
—
14.2
—
0
29
(3020891) Body temperature
36
258
1.41
1.15
4.0
4.5
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
7
30
2.34
1.12
1.1
2.0
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
7
30
2.34
1.12
1.1
2.0
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
20
127
1.59
1.12
1.1
1.3
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
7
31
2.27
1.10
1.1
2.0
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
59
461
1.30
1.10
2.2
1.8
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
78
633
1.25
1.08
1.9
2.1
nmol/l
10.7
12.6
0.94
69
563
(3025941) Bacteria identified in Stool by Culture
64
508
1.28
1.06
1.3
1.2
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
12
67
1.80
1.05
2.4
2.4
e6/l
1027.8
781.7
—
6
31
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
148
1286
1.18
1.03
4.3
3.5
ng/l
351.2
360.5
0.02
102
894
(3051593) INR in Capillary blood by Coagulation assay
5
22
2.28
1.03
10.2
15.4
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
34
2.07
1.03
1.0
1.1
—
—
—
0
0
(3000991) Gas panel - Venous blood
75
611
1.25
1.01
8.2
7.1
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
34
248
1.38
1.00
1.4
1.3
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
11
61
1.81
0.98
1.2
1.3
u/ml
0.1
0.4
—
6
24
(3002256) Pathology report gross observation
103
871
1.20
0.98
1.2
1.2
—
—
—
0
0
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
5
23
2.18
0.98
1.0
1.3
nmol/l
5.5
6.0
—
5
23
(3052851) Hemolysis interference index of Serum or Plasma
29
207
1.41
0.97
3.5
3.0
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
313
2880
1.12
0.97
1.7
1.7
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
10
54
1.86
0.96
1.4
1.2
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
12
69
1.75
0.96
1.0
1.2
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
31
0.00
0.96
0.0
1.0
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
67
543
1.25
0.96
1.0
1.1
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
14
85
1.66
0.94
1.0
1.0
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
7
37
1.90
0.94
2.3
1.4
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
200
1793
1.14
0.93
1.6
1.6
mmol/l
1.4
1.3
0.75
166
1531
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
6
27
2.23
0.93
1.2
1.2
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
6
27
2.23
0.93
2.0
1.6
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
807
7839
1.14
0.93
16.8
12.7
%
38.8
40.1
3.01
569
6023
(3004451) EKG impression Narrative
6
28
2.15
0.91
1.2
1.4
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
17
110
1.55
0.91
2.5
1.3
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
15
94
1.60
0.90
1.5
1.7
—
—
—
0
0
(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma
8
42
1.91
0.88
1.1
1.2
mu/l
463.6
321.2
—
8
37
(3023323) Follitropin [Units/volume] in Serum or Plasma
47
369
1.29
0.88
1.6
1.5
iu/l
14.6
13.8
0.09
37
300
(3009214) Lutropin [Units/volume] in Serum or Plasma
46
361
1.29
0.87
1.8
1.5
u/l
5.6
7.3
1.36
36
290
(3015377) Calcium [Moles/volume] in Serum or Plasma
253
2317
1.12
0.85
3.0
3.0
mmol/l
2.3
2.4
0.22
237
2038
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
13
80
1.63
0.84
1.1
1.1
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
6
31
1.94
0.84
1.2
1.2
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
231
2105
1.13
0.84
1.4
1.3
u/ml
1.8
1.5
0.18
63
536
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
43
336
1.29
0.84
2.8
2.3
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
19
129
1.48
0.83
1.2
1.4
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
12
190
0.63
0.83
1.8
2.3
g/l
37.4
38.2
0.26
12
162
(3018418) pH of Serum or Plasma
224
2040
1.12
0.82
4.0
3.7
ph
7.4
7.4
0.01
46
383
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
23
163
1.42
0.82
3.9
2.1
nmol/l
1.1
0.8
0.63
18
137
(3028433) Virus identified in Specimen by Culture
6
32
1.88
0.82
2.3
1.3
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
6
32
1.88
0.82
1.2
2.1
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
61
500
1.23
0.82
2.4
2.6
e9/l
4.6
4.1
0.46
50
402
(3051611) Lipemic interference index of Serum or Plasma
12
73
1.65
0.81
3.8
3.1
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
13
81
1.61
0.81
2.1
2.3
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
39
303
1.30
0.80
1.2
1.2
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
72
602
1.21
0.80
10.6
6.5
mmol/l
11.4
8.4
2.17
67
574
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
25
181
1.39
0.80
1.1
1.5
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
34
440
0.76
0.80
1.4
1.6
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
0
24
0.00
0.79
0.0
2.0
—
—
—
0
0
(3022145) Colonoscopy Study observation
92
789
1.18
0.78
1.4
1.3
—
—
—
0
0
(3042585) Pyridoxine [Moles/volume] in Serum or Plasma
0
27
0.00
0.77
0.0
1.4
—
100.0
—
0
19
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
39
305
1.29
0.77
1.5
1.6
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
20
140
1.44
0.77
2.2
2.5
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
66
787
0.83
0.77
4.7
6.4
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
6
34
1.77
0.76
1.3
1.6
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
40
315
1.28
0.76
7.5
9.1
mmol/l
24.6
24.6
0.04
33
298
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
15
99
1.52
0.75
2.0
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
15
99
1.52
0.75
2.0
1.5
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
5
24
2.09
0.74
1.2
1.2
ug/l
10.1
8.2
—
5
24
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
11
172
0.64
0.74
1.8
2.4
g/l
0.0
0.0
0.00
11
156
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
79
673
1.19
0.73
2.3
2.4
u/l
7046.2
7165.0
0.01
34
296
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
5
25
2.00
0.72
1.2
1.1
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
23
168
1.38
0.72
1.2
1.7
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
11
68
1.62
0.71
1.1
1.5
—
36.6
—
0
5
(3036071) Salmonella sp Ab [Titer] in Serum
7
40
1.75
0.71
1.1
1.1
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
11
170
0.64
0.71
1.8
2.5
g/l
0.0
0.0
0.00
11
155
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
28
212
1.33
0.70
1.5
1.2
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
15
101
1.49
0.70
2.0
1.4
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
15
101
1.49
0.70
2.0
1.4
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
15
101
1.49
0.70
2.0
1.4
—
—
—
0
0
(40758558) Short blood count panel - Blood
208
1906
1.11
0.70
6.2
6.5
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
7
41
1.71
0.70
3.1
2.7
u/ml
783.3
767.4
—
7
41
(1001926) Buprenorphine [Presence] in Urine by Screen method
65
548
1.20
0.69
2.0
2.0
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
75
641
1.18
0.68
2.1
2.0
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
10
61
1.65
0.68
3.5
3.3
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
5
27
1.86
0.68
1.2
1.3
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
9
59
1.53
0.68
1.0
1.2
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
136
1217
1.14
0.68
3.1
2.6
ug/g
170.1
124.1
0.56
115
964
(3012501) Base excess in Blood by calculation
20
144
1.40
0.68
7.2
3.0
mmol/l
2.5
2.2
0.15
13
91
(3005988) Vibrio sp identified in Specimen by Organism specific culture
15
102
1.48
0.67
2.0
1.4
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
21
153
1.38
0.67
1.6
1.6
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
7
43
1.63
0.67
1.1
1.6
—
—
—
0
0
(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay
7
43
1.63
0.67
2.4
4.7
—
28.4
—
0
9
(3014148) Varicella zoster virus Ab [Titer] in Serum
22
162
1.37
0.66
1.0
1.2
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
7
44
1.59
0.65
1.1
1.9
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
7
44
1.59
0.65
1.1
1.9
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
10
154
0.65
0.64
1.1
1.1
—
—
—
0
0
(3000492) Spirometry study
86
749
1.16
0.64
1.6
1.4
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
21
155
1.36
0.63
1.2
1.2
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
59
498
1.20
0.63
5.8
3.7
ng/l
95.5
77.0
0.46
49
446
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
12
79
1.52
0.62
1.0
1.5
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
32
253
1.27
0.61
1.1
1.1
u/ml
28.9
5.9
—
5
36
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
5
30
1.67
0.61
2.0
1.0
—
—
—
0
0
(4133840)
0
20
0.00
0.60
0.0
1.2
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
20
0.00
0.60
0.0
1.3
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
71
819
0.86
0.60
1.3
1.4
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
21
0.00
0.60
0.0
1.0
—
67.2
—
0
21
(3014111) Lactate [Moles/volume] in Serum or Plasma
69
594
1.17
0.60
6.1
6.5
mmol/l
1.3
1.3
0.16
64
563
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
60
511
1.18
0.59
4.0
2.4
ml/min/173m2
68.9
71.5
0.23
31
187
(4034850)
28
219
1.29
0.59
8.5
9.0
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
10
64
1.57
0.58
6.4
5.1
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
10
64
1.57
0.58
1.1
1.7
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
10
64
1.57
0.58
1.1
1.7
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
10
64
1.57
0.58
1.1
1.7
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
10
64
1.57
0.58
3.2
2.6
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
7
112
0.62
0.58
1.3
1.2
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
56
475
1.19
0.58
1.4
1.5
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
6
35
1.72
0.57
1.0
1.2
—
—
—
0
0
(3035880) pH of Pleural fluid
6
35
1.72
0.57
1.2
1.2
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
6
35
1.72
0.57
1.2
1.2
—
—
—
0
0
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
6
35
1.72
0.57
3.2
3.1
nmol/l
134.7
109.8
—
6
35
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
96
1077
0.88
0.56
3.1
3.1
ug/l
0.7
0.8
0.09
63
696
(3021387) Prolactin [Units/volume] in Serum or Plasma
57
486
1.18
0.56
1.5
1.6
mu/l
392.9
268.2
1.14
51
428
(3003327) Ova and parasites identified in Stool by Light microscopy
41
340
1.21
0.54
1.8
1.6
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
21
160
1.32
0.53
1.1
1.2
—
30.9
—
0
13
(40768443) Skin Pathology biopsy report
37
304
1.22
0.53
1.2
1.2
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
43
359
1.21
0.53
1.5
1.3
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
9
62
1.46
0.53
1.0
1.2
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
207
1927
1.09
0.53
2.1
2.2
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
22
170
1.30
0.51
1.0
1.1
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
179
1928
0.91
0.51
1.7
1.8
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
26
206
1.27
0.51
2.3
1.5
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
298
2821
1.08
0.51
2.0
2.1
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
9
65
1.39
0.50
1.1
1.2
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
34
279
1.23
0.50
1.6
1.5
iu/ml
48.1
0.2
—
10
57
(3006922) Hepatitis E virus Ab [Presence] in Serum
6
41
1.47
0.50
1.2
1.0
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
35
289
1.22
0.49
1.9
1.9
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
56
484
1.17
0.49
1.4
1.5
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
58
503
1.16
0.48
2.8
3.5
pmol/l
4.5
4.6
0.58
50
450
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
13
93
1.40
0.48
1.0
1.0
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
12
85
1.42
0.47
2.1
3.2
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
12
85
1.42
0.47
2.2
3.2
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
48
1.46
0.47
1.0
1.1
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
25
200
1.26
0.46
1.7
1.5
ug/g
258.4
300.0
0.43
14
114
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
60
524
1.15
0.46
1.8
2.4
ug/l
10.3
6.3
0.60
51
462
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
16
120
1.34
0.46
1.7
1.3
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
45
384
1.18
0.46
1.6
1.4
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
32
264
1.22
0.46
2.1
1.7
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
50
577
0.86
0.45
1.1
1.3
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
18
138
1.31
0.45
1.7
2.0
%
16.9
16.2
0.41
13
62
(3030905) Polymorphonuclear cells [#/volume] in Blood
19
147
1.30
0.45
4.9
3.5
e9/l
5.0
4.1
1.47
19
147
(3022217) INR in Platelet poor plasma by Coagulation assay
88
791
1.12
0.45
17.5
21.0
inr
1.1
1.3
0.74
12
124
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
23
183
1.26
0.45
1.1
1.5
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
7
50
1.40
0.45
1.0
1.2
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
7
50
1.40
0.45
1.9
2.0
—
2.0
—
0
6
(3023183) Ammonium ion [Moles/volume] in Plasma
13
174
0.74
0.43
2.9
2.9
umol/l
47.9
32.8
1.30
13
149
(3045142) Bone marrow Pathology biopsy report
11
78
1.41
0.43
1.4
1.4
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
54
472
1.15
0.42
1.4
1.5
—
—
—
0
0
(3024263) Appearance of Synovial fluid
5
32
1.56
0.42
2.0
1.6
—
—
—
0
0
(44790049)
6
95
0.63
0.42
1.3
1.3
—
—
—
0
0
(44806118)
6
95
0.63
0.42
1.3
1.3
—
—
—
0
0
(44790048)
6
95
0.63
0.42
1.3
1.3
—
—
—
0
0
(44790047)
6
95
0.63
0.42
1.3
1.3
—
—
—
0
0
(44806071)
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(3033923) Metanephrine [Moles/time] in 24 hour Urine
0
16
0.00
0.41
0.0
1.1
—
0.9
—
0
8
(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
13
172
0.75
0.41
1.2
1.1
—
—
—
0
0
(4306422)
15
114
1.32
0.40
1.2
1.2
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
17
0.00
0.40
0.0
1.0
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
5
34
1.47
0.40
1.2
1.1
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
19
150
1.27
0.40
5.1
3.8
%
63.3
56.3
1.74
19
150
(3039443) Prostate specific Ag panel - Serum or Plasma
7
103
0.68
0.39
1.1
1.5
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
72
646
1.12
0.39
1.4
1.5
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
66
589
1.13
0.39
1.3
1.5
—
—
—
0
0
(3022493) Free Hemoglobin [Mass/volume] in Plasma
5
35
1.43
0.39
1.4
1.4
mg/l
96.8
90.6
—
5
25
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
5
35
1.43
0.39
1.0
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
5
35
1.43
0.39
1.0
1.0
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
19
0.00
0.39
0.0
1.5
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
0
19
0.00
0.39
0.0
1.6
—
—
—
0
0
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
11
80
1.38
0.38
1.0
1.1
%
101.6
94.8
0.37
11
75
(44813793)
9
67
1.35
0.38
1.1
1.0
—
—
—
0
0
(21494434) Karyotype in Bone marrow
9
68
1.33
0.37
1.3
1.3
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
22
179
1.23
0.37
2.5
1.5
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
14
107
1.31
0.37
1.4
1.9
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
20
161
1.25
0.37
2.5
2.6
ug/min
81.1
69.3
0.14
11
99
(36660697) Celiac disease serology panel - Serum
65
723
0.89
0.37
1.3
1.2
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
201
1902
1.07
0.36
4.8
4.9
ug/l
2.2
2.6
0.84
180
1697
(1002224) Polysomnography panel
35
300
1.17
0.36
1.0
1.1
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
9
71
1.27
0.36
1.0
1.4
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
9
71
1.27
0.36
1.2
1.2
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
119
1280
0.92
0.35
1.7
1.5
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
78
709
1.11
0.35
2.3
2.2
u/l
34.7
32.5
0.24
68
589
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
19
233
0.81
0.35
1.5
1.9
iu/l
2.2
4.8
—
8
84
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
49
433
1.14
0.35
1.5
1.3
miu/ml
106.1
266.2
6.56
20
213
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
46
405
1.14
0.34
4.9
4.3
mmol/l
24.0
24.1
0.14
39
372
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
11
82
1.34
0.34
1.2
2.3
pg
33.1
33.2
0.03
11
82
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
10
133
0.75
0.33
1.4
1.6
—
1680.0
—
0
5
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
13
100
1.30
0.33
1.0
1.1
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
13
100
1.30
0.33
1.0
1.4
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
16
127
1.26
0.33
1.0
1.2
—
—
—
0
0
(40768793) Breast Pathology biopsy report
11
144
0.76
0.33
1.4
1.2
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
51
454
1.13
0.33
1.3
1.1
titre
95.0
156.6
—
5
13
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
6
46
1.31
0.33
1.5
1.3
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
65
588
1.11
0.33
1.4
1.5
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
130
1216
1.08
0.33
2.2
2.8
mmol/l
2.4
2.4
0.08
119
1059
(3021788) Differential panel - Synovial fluid
14
110
1.28
0.31
1.4
1.6
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
13
101
1.29
0.31
1.2
1.2
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
13
101
1.29
0.31
1.0
1.1
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
7
52
1.35
0.31
1.6
1.6
mmol/l
5.8
5.6
—
7
52
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
13
164
0.79
0.31
1.6
1.5
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
53
1.32
0.31
1.0
1.1
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
18
147
1.23
0.30
2.0
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
18
147
1.23
0.30
2.0
1.3
—
—
—
0
0
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
13
102
1.28
0.30
1.7
2.7
nmol/l
27.5
22.1
0.59
13
95
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
27
231
1.17
0.30
1.8
1.6
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
51
566
0.90
0.29
1.4
1.3
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
7
56
1.25
0.29
1.6
1.2
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
10
76
1.32
0.28
2.5
1.7
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
8
62
1.29
0.28
1.0
1.0
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
64
586
1.10
0.27
1.3
1.5
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
16
131
1.22
0.27
1.1
1.0
u/ml
2.6
1.8
—
8
66
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
8
65
1.23
0.27
1.1
1.1
—
—
—
0
0
(4146454)
8
65
1.23
0.27
3.6
2.7
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
8
65
1.23
0.27
1.1
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
8
65
1.23
0.27
1.1
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
8
65
1.23
0.27
1.1
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
8
65
1.23
0.27
1.1
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
8
65
1.23
0.27
1.1
1.1
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
10
77
1.30
0.26
2.5
1.8
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
119
1123
1.07
0.25
1.9
1.7
%
1.4
1.4
0.27
112
1002
(3044927) Protein electrophoresis panel - Urine
9
75
1.20
0.25
1.0
1.1
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
145
1380
1.06
0.24
1.8
1.5
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
20
171
1.17
0.23
1.3
1.4
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
5
39
1.28
0.23
2.8
2.9
—
—
—
0
0
(4094501)
16
134
1.20
0.23
1.1
1.1
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
11
88
1.25
0.22
2.4
1.6
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
16
189
0.84
0.22
3.3
2.1
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
7
95
0.73
0.22
3.7
1.6
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
131
1247
1.06
0.22
2.2
2.0
—
—
—
0
0
(3020356) Listeria sp identified in Specimen by Organism specific culture
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
10
0.00
0.21
0.0
2.1
—
—
—
0
0
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
12
0.00
0.21
0.0
1.6
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
8
102
0.78
0.21
1.1
1.1
g/l
1.4
1.5
—
8
88
(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.4
—
0.4
—
0
8
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
2.0
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
302
2939
1.04
0.21
2.1
2.0
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
26
230
1.13
0.20
1.2
1.3
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
19
219
0.86
0.20
1.5
2.2
g/l
3.6
3.2
0.83
14
171
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
1.9
—
2.4
—
0
6
(3029396) Erythrocyte agglutination [Presence] in Blood
6
49
1.23
0.20
7.0
3.4
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
12
99
1.21
0.19
1.1
1.3
—
66.4
—
0
6
(40761535) Cells panel - Urine sediment
60
559
1.08
0.19
2.6
3.3
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
11
90
1.22
0.19
4.2
1.9
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
63
589
1.07
0.19
1.3
1.5
—
—
—
0
0
(4281824)
6
53
1.13
0.18
1.0
1.1
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
27
242
1.12
0.18
3.7
2.5
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
14
119
1.18
0.17
1.0
1.1
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
7
62
1.13
0.17
1.3
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
25
278
0.90
0.17
1.3
1.2
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
15
129
1.16
0.17
1.5
4.6
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
8
69
1.16
0.16
1.0
1.1
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
80
759
1.06
0.16
1.5
1.5
—
—
—
0
0
(4027681)
8
72
1.11
0.16
1.0
1.3
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
13
111
1.17
0.15
1.2
1.4
mmol/l
74.8
69.4
—
8
95
(3015076) Soybean IgE Ab [Units/volume] in Serum
8
73
1.10
0.15
1.1
1.1
—
5.2
—
0
16
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
9
78
1.15
0.15
1.0
1.0
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
9
78
1.15
0.15
1.0
1.1
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
21
234
0.90
0.15
1.1
1.2
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
9
82
1.10
0.15
1.2
1.3
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
9
83
1.08
0.14
1.1
1.3
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
57
603
0.94
0.14
2.6
4.1
ug/l
24.2
33.3
0.14
42
494
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
200
2050
0.97
0.13
2.4
2.3
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
25
273
0.91
0.13
1.3
1.1
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
61
579
1.06
0.13
1.5
1.6
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
12
138
0.87
0.13
1.2
1.8
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
272
2773
0.97
0.13
3.2
2.4
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
92
886
1.04
0.12
1.6
1.4
—
—
—
0
0
(4035726)
57
542
1.05
0.12
1.5
1.4
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
31
333
0.93
0.12
2.4
1.8
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
13
114
1.14
0.11
1.1
1.1
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
11
95
1.16
0.11
1.2
1.2
u/l
13.8
62.9
1.14
11
83
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
47
496
0.94
0.11
1.6
1.5
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
23
212
1.09
0.10
1.9
1.3
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
25
269
0.93
0.10
1.3
1.1
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
121
1177
1.03
0.10
1.5
1.6
—
—
—
0
0
(4211845)
5
44
1.14
0.10
2.6
2.8
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
5
45
1.11
0.10
1.4
1.3
g/l
0.8
1.0
—
5
45
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
5
47
1.06
0.09
2.4
2.5
umol/l
57.6
51.4
—
5
38
(3037121) Protein [Mass/volume] in Urine
31
291
1.07
0.09
2.2
3.5
g/l
0.7
0.4
0.54
16
129
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
5
48
1.04
0.09
1.2
1.1
miu/ml
1500.0
1384.2
—
5
48
(3012441) Differential panel - Pleural fluid
5
60
0.83
0.08
1.6
1.5
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
5
61
0.82
0.08
1.4
1.6
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
236
2325
1.02
0.08
1.8
1.7
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
82
844
0.97
0.08
3.9
4.0
%
31.4
32.1
0.22
68
578
(3003434) Protein [Mass/volume] in Pleural fluid
8
74
1.08
0.07
1.5
1.5
g/l
34.0
31.2
—
8
64
(3004588) Protein electrophoresis panel - Serum or Plasma
39
408
0.95
0.07
1.5
2.3
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
58
560
1.04
0.07
1.6
3.0
e9/l
77.6
69.0
1.30
51
434
(3024928) Oxygen saturation in Venous blood
16
147
1.09
0.07
4.3
3.7
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
7
81
0.86
0.07
1.3
1.3
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
7
85
0.82
0.07
1.4
1.7
%
90.1
90.9
—
7
85
(3011985) Renin [Units/volume] in Plasma
9
86
1.05
0.07
1.3
1.4
mu/l
44.2
55.6
—
9
77
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
153
1503
1.02
0.07
4.5
4.3
%
21.6
20.9
0.24
79
698
(3035637) Corticotropin [Mass/volume] in Plasma
8
91
0.88
0.06
2.5
1.6
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
183
1856
0.98
0.06
2.2
2.1
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
17
158
1.08
0.06
1.2
1.2
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
67
688
0.97
0.06
1.2
1.2
iu/ml
121.9
145.1
0.19
27
264
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
12
131
0.91
0.05
1.0
1.1
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
12
131
0.91
0.05
1.4
1.3
u/ml
1.6
3.4
—
7
45
(3037756) Immunofixation for Serum or Plasma
14
129
1.09
0.05
1.2
1.6
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
57
554
1.03
0.05
2.1
1.7
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
11
101
1.09
0.04
1.3
1.3
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
11
119
0.92
0.04
2.1
2.7
u/ml
14.4
41.5
0.34
11
104
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
20
190
1.05
0.04
4.1
3.6
u/ml
0.3
0.4
—
10
116
(3019225) pH of Specimen
64
653
0.98
0.03
3.5
3.8
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
14
149
0.94
0.03
1.1
1.1
—
9.8
—
0
13
(3024891) Influenza virus A+B Ag [Presence] in Specimen
25
260
0.96
0.03
1.6
1.1
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
27
260
1.04
0.03
1.9
2.8
%
90.9
93.1
0.22
27
246
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
101
996
1.02
0.03
2.0
1.9
—
—
—
0
0
(4268621)
10
92
1.09
0.03
2.8
2.4
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
19
198
0.96
0.02
1.5
1.2
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
76
769
0.99
0.01
4.3
3.3
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
157
1559
1.01
0.01
1.6
1.5
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
12
113
1.06
0.01
1.4
1.4
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
27
263
1.03
0.01
2.2
2.2
umol/l
6.0
5.5
0.12
21
197
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
111
1102
1.01
0.01
2.0
2.0
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
13
124
1.05
0.00
1.0
1.2
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
24
234
1.03
0.00
1.5
2.2
g/l
4.0
3.7
0.45
14
169
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
24
234
1.03
0.00
1.5
2.2
g/l
8.1
7.3
0.82
14
177
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
24
234
1.03
0.00
1.5
2.2
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
11
111
0.99
0.00
1.0
1.6
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
18
178
1.01
0.00
1.4
1.1
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
18
175
1.03
0.00
1.6
4.0
ratio
1.6
2.1
—
7
17
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
30
295
1.02
0.00
1.4
1.4
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
18
180
1.00
0.00
1.2
1.2
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
18
180
1.00
0.00
1.4
1.1
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
29
286
1.01
0.00
1.9
1.5
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
37
374
0.99
0.00
1.4
1.6
mg/l
2.0
3.1
1.53
22
253
(3027945) Reticulocytes/100 erythrocytes in Blood
78
784
0.99
0.00
1.9
3.0
%
1.8
1.7
0.30
71
715
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
24
239
1.00
0.00
1.9
1.7
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
5
59
0.85
0.00
3.8
2.9
nmol/l
9.7
6.4
—
5
59
(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
5
55
0.91
0.00
1.0
1.4
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
7
79
0.89
0.00
1.0
1.1
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
6
60
1.00
0.00
1.5
1.3
—
—
—
0
0
(3029612) Listeria sp Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
6
65
0.92
0.00
1.8
1.7
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
9
0.00
0.00
0.0
1.2
—
1.9
—
0
9
(3039744) RNA polymerase III Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3049242) von Willebrand panel - Platelet poor plasma
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
6
67
0.89
0.00
2.8
1.2
—
—
—
0
0
(3007463) Buprenorphine [Presence] in Urine
0
6
0.00
0.00
0.0
7.0
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
0
7
0.00
0.00
0.0
2.4
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay
0
8
0.00
0.00
0.0
2.8
—
5.2
—
0
8
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
0
5
0.00
0.00
0.0
5.8
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
8
83
0.96
0.00
1.0
1.1
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3027570) Oxalate [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
253.6
—
0
5
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009677) Dengue virus Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036180) Methadone [Presence] in Urine
0
5
0.00
0.00
0.0
2.8
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
6
68
0.88
0.00
2.8
1.2
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint H8_SUP_OTINAS and mortality.

Females

Parameter HR [95% CI] p-value
H8_SUP_OTINAS 1.229 [1.1, 1.37] < 0.001
Birth year 0.995 [0.99, 1.0] 0.263

During the follow-up period (1.1.1998 — 31.12.2019), 641 out of 3842 females with H8_SUP_OTINAS died.

Males

Parameter HR [95% CI] p-value
H8_SUP_OTINAS 1.206 [1.08, 1.35] < 0.001
Birth year 0.986 [0.98, 1.0] 0.003

During the follow-up period (1.1.1998 — 31.12.2019), 752 out of 4438 males with H8_SUP_OTINAS died.

Mortality risk

Mortality risk for people of age

years, who have H8_SUP_OTINAS.

N-year risk Females Males
1 0.15% 0.237%
5 0.584% 1.523%
10 1.543% 3.554%
15 3.269% 6.65%
20 5.801% 11.043%

Relationships between endpoints

↥

Index endpoint: H8_SUP_OTINAS – Suppurative otitis media, unspecified

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data